CareLit · DOI-Nachweis · Pneumologie
Efficacy of aclidinium/formoterol fixed-dose combination versus salmeterol/fluticasone in COPD
DOI 10.1055/s-0036-1572048
Bibliografische Angaben
Nachweis in CareLit
Autor:innenC Vogelmeier, P Paggiaro, J Dorca, P Sliwinski, M Mallet, AM Kirsten, B Seoane, RM Segarra, A Leselbaum, EG Gil
ZeitschriftPneumologie
Ausgabe02/2016
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: Aclidinium bromide/formoterol fumarate fixed-dose combination (FDC) twice daily (BID) is licensed in Europe for COPD treatment. Aim: To evaluate the efficacy of aclidinium/formoterol vs. salmeterol/fluticasone propionate FDC (SAL/FLU) in patients with COPD. Methods: A randomised, double-blind, Phase IIIb, 24-week study in patients with COPD Assessment Test (CAT) score ≥10 compared aclidinium/formoterol 4…
Zitieren
Zitierempfehlung
C Vogelmeier, P Paggiaro, J Dorca, P Sliwinski, M Mallet, AM Kirsten, B Seoane, RM Segarra, A Leselbaum, EG Gil (2016) Efficacy of aclidinium/formoterol fixed-dose combination versus salmeterol/fluticasone in COPD. Pneumologie (02). https://doi.org/10.1055/s-0036-1572048
Mit CareLit weiterarbeiten